Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis - PubMed

Clinical Trial

Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis

P Kullavanijaya et al. J Am Acad Dermatol. 1997 Aug.

Comment in

• Terbinafine.

  Shwayder T. Shwayder T. J Am Acad Dermatol. 1998 Jul;39(1):136. doi: 10.1016/s0190-9622(98)70421-9. J Am Acad Dermatol. 1998. PMID: 9674414 No abstract available.

Similar articles

• Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.

  Filho ST, Cucé LC, Foss NT, Marques SA, Santamaria JR. Filho ST, et al. J Eur Acad Dermatol Venereol. 1998 Sep;11(2):141-6. J Eur Acad Dermatol Venereol. 1998. PMID: 9784040 Clinical Trial.

• Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study.

  Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P, Stewart D, Lucky AW, Gupta AK, Babel DE, Abrams B, Gourmala N, Wraith L, Paul C; Tinea Capitis Study Group. Friedlander SF, et al. Pediatrics. 2002 Apr;109(4):602-7. doi: 10.1542/peds.109.4.602. Pediatrics. 2002. PMID: 11927703 Clinical Trial.

• A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.

  Lipozencic J, Skerlev M, Orofino-Costa R, Zaitz VC, Horvath A, Chouela E, Romero G, Gourmala N, Paul C; Tinea Capitis Study Group. Lipozencic J, et al. Br J Dermatol. 2002 May;146(5):816-23. doi: 10.1046/j.1365-2133.2002.04744.x. Br J Dermatol. 2002. PMID: 12000378 Clinical Trial.

• The efficacy and safety of terbinafine in children.

  Gupta AK, Cooper EA, Lynde CW. Gupta AK, et al. Dermatol Clin. 2003 Jul;21(3):511-20. doi: 10.1016/s0733-8635(03)00029-9. Dermatol Clin. 2003. PMID: 12956204 Review.

• [Tinea capitis. Therapeutic options in the post-griseofulvin era].

  Möhrenschlager M, Korting HC, Seidl HP, Ring J, Abeck D. Möhrenschlager M, et al. Hautarzt. 2002 Dec;53(12):788-94. doi: 10.1007/s00105-002-0365-5. Hautarzt. 2002. PMID: 12444518 Review. German.

Cited by

• Antifungal agents for common paediatric infections.

  [No authors listed] [No authors listed] Paediatr Child Health. 2000 Nov;5(8):477-91. doi: 10.1093/pch/5.8.477. Paediatr Child Health. 2000. PMID: 20177562 Free PMC article. No abstract available.

• Antifungal agents for common paediatric infections.

  [No authors listed] [No authors listed] Paediatr Child Health. 2007 Dec;12(10):875-83. doi: 10.1093/pch/12.10.875. Paediatr Child Health. 2007. PMID: 19043507 Free PMC article. No abstract available.

• Systemic antifungal therapy for tinea capitis in children.

  Chen X, Jiang X, Yang M, González U, Lin X, Hua X, Xue S, Zhang M, Bennett C. Chen X, et al. Cochrane Database Syst Rev. 2016 May 12;2016(5):CD004685. doi: 10.1002/14651858.CD004685.pub3. Cochrane Database Syst Rev. 2016. PMID: 27169520 Free PMC article. Review.

• Safety and efficacy of terbinafine in a pediatric Iranian cohort of patients with Tinea capitis.

  Sabzghabaee AM, Mansouri P, Mohammadi M. Sabzghabaee AM, et al. Saudi Pharm J. 2009 Jul;17(3):243-8. doi: 10.1016/j.jsps.2009.08.003. Epub 2009 Aug 7. Saudi Pharm J. 2009. PMID: 23964167 Free PMC article.

• Antifungal agents for common paediatric infections.

  [No authors listed] [No authors listed] Can J Infect Dis Med Microbiol. 2008 Jan;19(1):15-8. Can J Infect Dis Med Microbiol. 2008. PMID: 19145261 Free PMC article. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.